Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A National Strategy to Detect and Treat Heart Valve Diseases in Canada.
Forcillo J, Wood DA, Abdel-Razek O, Adreak N, Asgar A, Chedrawy E, Eckstein J, Legare JF, Natarajan MK, Pibarot P, Styra R, Tyrrell B, Wijeysundera H, Messika-Zeitoun D; Canadian Cardiovascular Society Working Group on Heart Valve Disease. Forcillo J, et al. Can J Cardiol. 2023 May;39(5):567-569. doi: 10.1016/j.cjca.2023.01.021. Epub 2023 Jan 27. Can J Cardiol. 2023. PMID: 36716859 No abstract available.
Significant Valvular Dysfunction and Outcomes in Cardiogenic Shock: Insights From the Randomized DOREMI Trial.
Parlow S, Weng W, Di Santo P, Jung RG, Lepage-Ratte MF, Motazedian P, Prosperi-Porta G, Abdel-Razek O, Simard T, Chan V, Labinaz M, Froeschl M, Mathew R, Hibbert B; CAPITAL DOREMI Investigators. Parlow S, et al. Can J Cardiol. 2022 Aug;38(8):1211-1219. doi: 10.1016/j.cjca.2022.04.004. Epub 2022 Apr 14. Can J Cardiol. 2022. PMID: 35430192 Clinical Trial.
No sex-based difference in cardiogenic shock: A post-hoc analysis of the DOREMI trial.
Prosperi-Porta G, Motazedian P, Di Santo P, Jung RG, Parlow S, Abdel-Razek O, Simard T, Hutson J, Malhotra N, Fu A, Ramirez FD, Froeschl M, Mathew R, Hibbert B; CAPITAL DOREMI investigators. Prosperi-Porta G, et al. J Cardiol. 2022 Oct;80(4):358-364. doi: 10.1016/j.jjcc.2022.06.001. Epub 2022 Jun 17. J Cardiol. 2022. PMID: 35725945 Free article. Clinical Trial.
Arrhythmic Events and Mortality in Patients With Cardiogenic Shock on Inotropic Support: Results of the DOREMI Randomized Trial.
Jung RG, Di Santo P, Mathew R, Simard T, Parlow S, Weng W, Abdel-Razek O, Malhotra N, Cheung M, Hutson JH, Marbach JA, Motazedian P, Thibert MJ, Fernando SM, Nery PB, Nair GM, Russo JJ, Hibbert B, Ramirez FD. Jung RG, et al. Can J Cardiol. 2023 Apr;39(4):394-402. doi: 10.1016/j.cjca.2022.09.013. Epub 2022 Sep 20. Can J Cardiol. 2023. PMID: 36150583 Clinical Trial.
Western Database of Lipid Variants (WDLV): a catalogue of genetic variants in monogenic dyslipidemias.
Fu J, Kwok S, Sinai L, Abdel-Razek O, Babula J, Chen D, Farago E, Fernandopulle N, Leith S, Loyzer M, Lu C, Malkani N, Morris N, Schmidt M, Stringer R, Whitehead H, Ban MR, Dubé JB, McIntyre A, Johansen CT, Cao H, Wang J, Hegele RA. Fu J, et al. Can J Cardiol. 2013 Aug;29(8):934-9. doi: 10.1016/j.cjca.2013.01.008. Epub 2013 Apr 24. Can J Cardiol. 2013. PMID: 23623477
Rationale and Design of the Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion Trial (CAPITAL-RAPTOR).
Di Santo P, Abdel-Razek O, Jung R, Parlow S, Poulin A, Bernick J, Morgan B, Robinson L, Feagan H, Wade J, Goh CY, Singh K, Froeschl M, Labinaz M, Fergusson DA, Coyle D, Kyeremanteng K, Abunassar J, Wells GA, Simard T, Hibbert B. Di Santo P, et al. Among authors: abdel razek o. BMJ Open. 2023 May 12;13(5):e070720. doi: 10.1136/bmjopen-2022-070720. BMJ Open. 2023. PMID: 37173116 Free PMC article. Clinical Trial.
Transcatheter mitral valve repair for inotrope dependent cardiogenic shock - Design and rationale of the CAPITAL MINOS trial.
Parlow S, Di Santo P, Jung RG, Fam N, Czarnecki A, Horlick E, Abdel-Razek O, Chan V, Hynes M, Nicholson D, Dryden A, Fernando SM, Wells GA, Bernick J, Labinaz M, Mathew R, Simard T, Hibbert B. Parlow S, et al. Am Heart J. 2022 Dec;254:81-87. doi: 10.1016/j.ahj.2022.08.008. Epub 2022 Aug 21. Am Heart J. 2022. PMID: 36002047 Clinical Trial.
Impact of atrial fibrillation on the risk of major adverse cardiac events following coronary revascularisation.
Jung RG, Abdel-Razek O, Di Santo P, Gillmore T, Stotts C, Makwana D, Soriano J, Moreland R, Verreault-Julien L, Goh CY, Parlow S, Sypkes C, Ramirez DF, Sadek M, Chan V, Toeg H, Simard T, Froeschl MPV, Labinaz M, Hibbert B. Jung RG, et al. Open Heart. 2022 Sep;9(2):e002012. doi: 10.1136/openhrt-2022-002012. Open Heart. 2022. PMID: 36150746 Free PMC article.
Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
Mathew R, Di Santo P, Jung RG, Marbach JA, Hutson J, Simard T, Ramirez FD, Harnett DT, Merdad A, Almufleh A, Weng W, Abdel-Razek O, Fernando SM, Kyeremanteng K, Bernick J, Wells GA, Chan V, Froeschl M, Labinaz M, Le May MR, Russo JJ, Hibbert B. Mathew R, et al. N Engl J Med. 2021 Aug 5;385(6):516-525. doi: 10.1056/NEJMoa2026845. N Engl J Med. 2021. PMID: 34347952 Clinical Trial.
45 results